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Objective: To analyze vitamin D status based on serum 25-hydroxyvitamin D (25OHD) 
measurements, its determinants and health correlates in a representative sample of German adults. 
Subjects: A total of 1763 men and 2267 women, 18- to 79-year old, who participated in the 
representative German National Health Interview and Examination Survey 1998 and the integrated 
German Nutrition Survey. 
Results: The median vitamin D intake from both diet and supplements did not meet the recommended 
level of 5 mg/day, in either men (2.8 mg/day) or women (2.3 mg/day). Altogether 80.9% of men and 
88.5% of women had vitamin D intakes below this level. Moderate (12.5–25 nmol/l serum 25OHD 
levels) and mild (25–50 nmol/l) vitamin D deficiency was prevalent in the adult population in Germany, 
even in younger age groups. Overall, 57% of men and 58% of women had vitamin D levels below 50 
nmol/l. Among 65- to 79-year-old women, the proportion amounted to 75%, even during the sunnier 
half of the year. In sexspecific multiple linear regression models, independent determinants of serum 
25OHD levels consistently included season, vitamin D intake from both diet and supplements, physical 
activity and living in a partnership. In addition, age and current menopausal hormone use contributed 
to the model among women, as opposed to time of day of blood sampling and body 
mass index (marginally) among men. Significantly lower serum 25OHD levels were observed in 
women with hypertension, cardiovascular diseases and noninsulin-treated diabetes mellitus as well as 
in men with insulin-treated diabetes mellitus compared with nonaffected participants. Conclusions: 
Vitamin D deficiency is a public health issue in Germany. We identified a number of determinants with 
potential for primary prevention of vitamin D deficiency. Risk and benefits of preventive actions need to 




Vitamin D plays a vital role in maintenance of calcium homeostasis. Currently, in Europe and North 
America, rickets and osteomalacia, the clinical outcomes of a severe vitamin D deficiency, are rarely 
observed (Lips, 2004). Milder states of vitamin D deficiency are more common and may contribute to 
the risk of fragility fractures in the elderly on the basis of secondary hyperparathyroidism and high 
bone turnover (Avenell et al., 2005) as well as muscle weakness and an increased propensity to falls 
(Bischoff-Ferrari et al., 2004). Beyond these musculoskeletal effects, long-standing suboptimal 
vitamin D states as defined by serum 25-hydroxyvitamin D (25OHD) levels below 50nmol/l may 
contribute to the pathogenesis of chronic conditions involving the immune system and low-grade 
inflammation, such as multiple sclerosis, type 1 and 2 diabetes, cardiovascular diseases and specific 
types of cancer (Chiu et al., 2004; Holick, 2004b; Zittermann et al., 2005; Christakos et al., 2006; 
Garland et al., 2006; Vieth and Kimball, 2006). A recent study suggests that lower serum 25OHD 
levels are also associated with a greater risk of future nursing home admission and possibly with 
mortality in older persons (Visser et al., 2006). It is well known that vitamin D status shows a marked 
seasonal variation as ultraviolet-B radiation is not strong enough during winter time to assure sufficient 
dermal synthesis of vitamin D. Vitamin D deficiency states appear to be prevalent in populations of 
different latitudes and ethnic backgrounds (Mc Kenna, 1992; Ovesen et al., 2003; Hashemipour et al., 
2004; Heaney, 2004; Meyer et al., 2004; Raiten and Picciano, 2004; Gannage-Yared et al., 2005; 
Hanley and Davision, 2005; Lucas et al., 2005; Meddeb et al., 2005; Park and Johnson, 2005; Whiting 
and Calvo, 2005). Specific risk factors of vitamin D deficiency mediated by lack of sunshine exposure 
include residence at high latitudes and in large cities, high skin pigmentation, cultural dress code or 
immobility (Semba et al., 2000; Hashemipour et al., 2004; Meyer et al., 2004; Meyer, 2004; Gannage-
Yared et al., 2005). Insufficient dietary compensation (Calvo et al., 2005), and diseases interfering with 
vitamin D and calcium absorption (Lips, 2004) have a role as well. Previous studies among the adult 
population in Germany showed that the average dietary vitamin D intake does not meet the 
recommended level (Mensink et al., 2002; DGE, 2004). However, information regarding vitamin D 
status and potential health correlates in Germany is scarce. Data available so far relate to vitamin D 
deficiency among residents of older people’s homes (Mc Kenna, 1992) and to the association between 
serum 25OHD levels and bone mineral density or bone metabolism in a small regional sample of older 
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adults (Scharla et al., 1996; Woitge et al., 1998). The present study aimed to assess the prevalence of 
vitamin D deficiency and replete states in a representative sample of the German noninstitutionalized 
adult population and to examine some independent determinants of vitamin D status as well as the 
cross-sectional relationship between serum 25OHD levels and several common chronic conditions 
previously related to vitamin D deficiency. 
 
 
Subjects and methods 
 
Subjects 
The representative German National Health Interview and Examination Survey 1998 (GNHIES) was 
conducted from October 1997 to March 1999. The population sample included 7124 men and women, 
aged 18–79 years, reflecting the noninstitutionalized adult population in Germany. Participants were 
selected by a random sampling method based on a two-staged clustered design, stratified by age, 
community size and federal state. The response rate was 61.4% (Bellach et al., 1998; Thefeld et al., 
1999). The  sampling procedure has been previously described in detail (Mensink and Beitz, 2004). 
The present analysis is based on a random subsample of 2267 women and 1763 men who also 
participated in an extended dietary assessment, the German Nutrition Survey 1998. As budget and 
time restrictions precluded to include all persons who responded to the main survey, participants were 
recruited consecutively according to interviewer availability without any systematic selection. As an 
exception, we attempted to cover the largest possible proportion of women of childbearing age 
assuring a sufficient number of participants for the allied folic acid study. To correct for this 
disproportionality as well as for discrepancies due to nonresponse and noncoverage between the net 
sample and the situation of the German population according to age, gender, community size and 
residence in West or East Germany in 1998, a weighting factor was computed (Mensink and Beitz, 
2004). Surveys were approved by the federal data protection office. Respondents were informed in 
detail about the study objectives, interview and examination procedures as well as pseudonymized 
record-keeping and data analyses. All participants provided written informed consent before the 
interview and examination.  
 
Data collection  
Participants filled in a questionnaire on health and lifestyle issues, among them leisure-time physical 
activity, income, education and profession. A computer-assisted personal interview (CAPI) was 
conducted by specifically trained physicians to obtain a detailed medical history and information on 
any medication used within 7 days before the interview. To assess the lifetime diagnosis of particular 
health problems, including various cardiovascular conditions as well as diabetes mellitus, participants 
were asked ‘Has a doctor ever told you that you have one or more of the following diseases?’. 
Diabetes mellitus was further differentiated 
as noninsulin-treated and insulin-treated diabetes mellitus. Standardized measures of blood pressure, 
height and weight as well as blood samples were taken as part of a medical examination. Blood 
pressure was measured by a physician 3 times after at least 3min rest, using a mercury 
sphygmomanometer (Erkameter 3000, Erka, Bad Jölz, Germany). Mean systolic and diastolic blood 
pressure was calculated from the second and the third measurements.  
Laboratory analyses  
The participants were asked to fast for at least 3 h, whereupon venous blood samples were drawn for 
biochemical analyses. Blood samples were immediately processed and separated. Whole blood and 
the larger part of serum were immediately used for analysis of hematologic parameters and blood 
chemistry. Extra serum was aliquoted and stored at _401C. Total serum calcium was measured by 
cresolphthalein complexon method (Merck, Darmstadt, Germany) on a Mega-Analyzer. Calcium levels 
were corrected for serum 
albumin (Rustad et al., 2004). The best indicator of vitamin D status is serum 25OHD. Serum 25OHD 
levels and serum intact parathyroid hormone levels (iPTH) were both measured from June to 
September 2005 in the Epidemiological Research Laboratory of the Robert Koch-Institute, using 
LIAISON chemiluminescence immunoassay (CLIA) (DiaSorin Inc., Stillwater, MN, USA). Inter- and 
intraassay coefficients of variation for serum 25OHD were 11.7 and 9.9% and for serum iPTH 7.2 and 
3.7%, respectively. The lower detection limits of the assays were 5 nmol/l for serum 25OHD and 0.106 
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Dietary assessment 
Trained nutritionists interviewed the participants about their dietary habits in the past 4 weeks before 
the examination, using the computerized modified dietary history instrument DISHES 98 (Dietary 
Interview Software for Health Examination 
Studies) with documented validity (Mensink et al., 2001). Special tableware and drawings of food 
portions helped to facilitate the estimations of portion sizes. The individual nutrient intake from the 
information on food consumption was calculated using the German Food Consumption Table, Version 
2.3 (Dehne et al., 1999). As part of the dietary interview, the participants were asked about their use of 
vitamin B complex, C, E, folic acid, multivitamin and mineral supplements during the last year. This 
included the frequency of intake as well as the corresponding brand names of the supplements. 
Besides, there was the possibility to provide open-ended information about the use of other vitamins, 
for example vitamin D. Based on the brand names, the quantities of supplement ingredients were 
calculated, using an updated supplement composition database, developed by the GSF – National 
Research Centre for Environment and Health (Beitz et al., 2002).  
 
Operationalization of variables  
Vitamin D status was categorized into groups, according to Lips as serum 25OHD levels o12.5 nmol/l, 
12.5–25 nmol/l, 25–50 nmol/l and 450 nmol/l, indicating severe, moderate and mild vitamin D 
deficiency as well as the desirable safe reference limit, respectively (Lips, 2004). For each individual, 
daily intakes of vitamin D (in mg/day) and calcium (in mg/day) from both diet and supplements were 
calculated from dietary assessment data. In addition, supplement use of vitamin D and calcium was 
indicated by dichotomous variables (yes vs no). Estimates of resting energy expenditure (REE) were 
computed from new standard equations based on height, weight, age and sex, according to specific 
body mass index (BMI) groups derived from German individuals (Müller et al., 2004). Energy intake 
(EI, in MJ/day) from diet was calculated and the ratio between EI and REE (EI/REE) was assessed to 
examine the potential influence of EI on vitamin D status. For some analyses, the study group was 
classified into age groups of 18–34, 35–64 and 65–79 years. Information on current month of 
examination was categorized according to calendar seasons: spring (March–May), summer (June–
August), autumn (September–November) and winter (December–February). Time of day of blood 
sampling was categorized as morning (0800–1300), noon/afternoon (1300– 1800) and evening (1800–
2200). Information on physical activity was defined using the question ‘How often do you engage in 
sports?’ as inactive (no engagement in sports), moderately active (1–2 h/week) and active (X2 
h/week). However, survey questions on physical activity were not designed to permit any further 
differentiation between indoor and outdoor physical activity. BMI was calculated by dividing weight (in 
kg) by squared height (in meters). BMI measures were categorized in four groups: underweight (o20 
kg/m2), normal weight (20 to o25 kg/m2), overweight (25 to o30 kg/m2) and obese (X30 kg/m2). In 
addition, information on social and professional status was included in the analyses as the 
dichotomous variables ‘outdoor working’ as well as ‘married or living with a partner’. A lifetime 
diagnosis of any cardiovascular disease was based on reported lifetime diagnosis of any one or more 
of the following conditions: previous  yocardial infarction or stroke, angina, cerebral ischemia, 
congestive heart failure and intermittent claudication of the leg.  Hypertension was defined as 
X90mmHg diastolic or X140mmHg systolic blood pressures according to Joint National Committtee 
criteria for stage 1 and 2 hypertension (Chobanian et al., 2003). In addition, participants with current 
antihypertensive medication were labeled as hypertensives irrespective of blood pressure 
measurements. With respect to other medication use, current uses of ‘antiepileptic therapy’ as well as 
‘menopausal hormone therapy’ among women were considered in the analyses as potential  
confounders due to their known effect on calcium and bone metabolism. 
 
Statistical analyses 
All statistical analyses were performed using the SAS-software package Version 9.1. (SAS Institute 
Inc., Carry, NC, USA). They were performed sex specifically, and a P-value of p0.05 was considered 
statistically significant based on two-sided tests. No adjustment for multiple testing was applied. The 
weighting factor was used for all analyses. The distribution of serum 25OHD levels was skewed and 
required logarithmical transformation for the multiple linear regression models. Values for seasonal 
variation were given as individual data points for serum 25OHD levels and serum iPTH levels. 
Both curves were fitted using a periodic function: F (month)¼ax1þbx2þC, where x1¼cos(month*p/6) 
and x2¼sin(month*p/6). These variations were similar for both sexes and were therefore not shown 
separately. Unadjusted associations between serum 25OHD levels and explanatory variables were 
first tested using w-square statistics, simple linear regression and Pearson’s as well as Spearman’s 
correlation analyses, suitable for the nature and distribution of the variables. Differences in serum 
25OHD levels between BMI groups were tested using the Kruskal–Wallis test. In addition, a multiple 
linear regression model with log serum 25OHD levels as the dependent variable was constructed to 
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identify the importance of determinants. For this purpose, we excluded participants with antiepileptic 
therapy (n¼31) to make sure that the observed association was not biased by this prevailing 
treatment. Antiepileptic drugs are inducers of the cytochrome P450 system in the liver, promoting the 
metabolism of 25OHD to less biologically active analogs (Kulak et al., 2004; Mintzer et al., 2006). We 
calculated prevalence rates across sex-specific quartiles of serum 25OHD levels to examine the 
association between serum 25OHD levels and hypertension as well as a lifetime diagnosis of diabetes 
mellitus and cardiovascular disease. The association between serum 25OHD levels and these 
conditions was further examined in multiple logistic regression analysis. Separate models were fitted 
for the various dependent variables including serum 25OHD levels as a continuous variable as well as 
the following covariates: age (continuous), calendar season and time of day of blood sampling 
(ordinate variables). Reported odds ratios, 95% confidence intervals and P-values relate to increase in 
serum 25OHD levels per 10 nmol/l. 
 
Results 
Characteristics of the study population are summarized in Table 1 for men and women separately. 
Median serum 25OHD levels were 45.2 nmol/l for men and 44.7 nmol/l for women. We observed that 
median vitamin D intake from both diet and supplements did not meet the recommended level, in 
either men (2.81 mg/day) or women (2.31 mg/day). Overall, 80.9% of men and 88.5% of women had 
vitamin D intakes below the recommended 5 mg/day (data not shown). Median calcium intake of both 
men (1181 mg/day) and women (1082 mg/day) reached the recommended 1000 mg/day. A small 
amount of 1.5% of men and 3.8% of women used vitamin D supplements, whereas 12.1% of men and 
19.3% of women reported use of calcium supplements. There was no age gradient in Vitamin D 
supplement use but a smaller amount in summer compared to winter (data not shown). Seasonal 
variation in serum 25OHD levels is demonstrated in Figure 1a. There were disparities throughout the 
year in vitamin D status with the highest median observed in summer (56.6 nmol/l in June) and the 
lowest at the end of winter (33.2 nmol/l in March). Furthermore, the largest variability occurred during 
winter while a smaller variability was seen in summer. Seasonal declines in serum 25OHD 
levels were closely mirrored by increases in serum iPTH levels (Figure 1b). Sex- and age-specific 
prevalence rates of vitamin D status for the sunnier (May–October) and sun-deprived (November– 
April) half of the year are shown in Table 2. In the total sample, 56.8% of men and 57.8% of women 
showed serum 25OHD levels of 50nmol/l and below. Vitamin D deficiency and replete states were 
strongly related to season with the highest prevalence of replete states during sunnier months 
compared to sun-deprived months. From May to October replete vitamin D states were generally more 
prevalent in men than in women, whereas the reverse was true from November to April except for the 
highest age group. There was a strong age dependency of vitamin D status in women but not in men. 
Even from May–October, nearly 75% of the 65- to 79-year-old women had serum 25OHD levels below 
50nmol/l. We found several significant associations between vitamin D status and potential 
determinants (as shown in Table 1) in bivariate analyses. Calcium intake from both diet and 
supplements as well as EI/REE was not significantly correlated with serum 25OHD levels. EI/REE was 
strongly and inversely correlated with BMI. In both sexes, serum 25OHD levels varied significantly 
between different BMI groups with the lowest levels in both low and high BMI, indicating a curvilinear, 
U-shaped association. Box plots of serum 25OHD levels by BMI groups for men and women, 
respectively, showed this relationship (Figure 2a and b). In full multiple linear regression models, 
season, vitamin D intake, married or living with a partner and being physically active were significantly 
and positively associated with serum 25OHD levels in both sexes (Table 3). In addition, age and 
current menopausal hormone therapy were independent determinants of serum 25OHD levels in 
women, whereas time of day of blood sampling independently contributed to the model in men. BMI at 
the lower and upper end of the distribution (U-shaped relationship as reflected by the squared term) 
was marginally significant in men. Calcium intake did not contribute to the multiple models in either 
sex, estimates in Table 3 are therefore based on the models without calcium intake. Due to the strong 
correlation between BMI and EI/REE, the potential effect of EI/REE was examined in separate models 
replacing BMI by EI/REE. We observed no significant effect on serum 25OHD levels. Men with lower 
serum 25OHD levels were more likely to have insulin-treated diabetes mellitus. However, the number 
of observations was rather small (1.1% in men and 1.2% in women). Among women, hypertension and 
a reported lifetime diagnosis of cardiovascular disease and noninsulintreated diabetes mellitus were 
associated with lower serum 25OHD levels. Prevalence rates showed a significant stepwise increase 
from highest to lowest 25OHD quartiles (Table 4a). These associations persisted in multiple logistic 
models adjusted for age, season and time of day of blood sampling (Table 4b). In addition, the 
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TABLE 1 Participant characteristics by gender a  
Variable      Men (n=1763)   Women (n=2267) 
Serum levels b 
25OHD (nmol/l)    45.2 (30.5-68.6)   44.7 (30.7-72.2) 
iPTH (pmol/l)    3.5 (2.2-4.9)   2.9 (1.7-4.5) 
Calcium, corr. (mmol/l)   2.14 (2.06-2.21)   2.18 (2.10-2.26) 
Dietary intake (from diet and supplements) 
EI/REE (MJ/d) c    1.40 (1.13-1.73)   1.32 (1.10-1.60) 
Vitamin D (µg/d)    2.81 (1.89-4.44)   2.31 (1.53-3.56) 
Calcium (mg/d)    1181 (902-1535)   1082 (849-1379) 
Supplement use (%) 
 Vitamin D (yes)      1.5      3.8 
 Calcium (yes)    12.1    19.3 
Age group (%)       
18-34 y      30.7    27.8 
35-64 y      55.4    52.5 
65-79 y     13.9    19.7 
Season of examination (%) 
Spring (March-May)   33.6    32.3 
Summer (June-August)   17.9    17.4 
Autumn (September-November)   36.9    39.7 
Winter (December-February)   11.6    10.6 
Time of day of blood sampling (%) b 
 Morning     30.5    49.6 
 Noon/afternoon    35.3    36.5 
 Evening     33.7    12.9 
Leisure time physical activity (%) b 
Inactive     40.5    45.5 
Moderately active (1-2 h/week)   33.7    38.0 
Active (≥2 h/week)    25.4    16.1 
Body mass index (%) 
<20 kg/m² (underweight)     1.9      6.4 
20-25 kg/m² (normal weight)   30.9    40.5 
25-30 kg/m² (overweight)   49.4    31.4 
>30 kg/m² (obesity)    17.8    21.7 
Social and professional status (%) b 
Married or living with a partner (yes)  76.7    71.1 
Outdoor working (yes)   37.7    23.3 
Medical history of diseases (%) b 
Hypertension (yes)    20.3    24.0 
Cardiovascular disease (yes)   11.1    12.1 
Insulin treated diabetes mellitus (yes)    1.1      1.2 
Non-insulin treated diabetes mellitus (yes)    3.5      4.9 
Medication use (%) b 
Antiepileptic therapy (yes)     0.7      0.8 
Menopausal hormone therapy (yes)    -    11.9 
a Data are presented as median and interquartile range (25th - 75th Percentile) or percentage as indicated. 
b Marked variables show few missing values (therefore, the sum of these variables is not 100%).  
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Figure 1 (a) Values for seasonal variation are given as individual data points for serum 25OHD levels. The curve is fitted using a 
periodic function: F (month)¼ax1þbx2þC, where x1¼cos (month p/6) and x2¼sin (month p/6), Po0.001. The median 
25OHD levels were lower in winter than in summer. The lowest median was observed at the end of winter (March), the highest 
median in summer (June). (b) Values for seasonal variation are given as individual data points for serum iPTH levels. The curve 
is fitted using a periodic function: F (month)¼ax1þbx2þC, where x1¼cos (month p/6) and x2¼sin (month p/6), Po0.001. Serum 
iPTH levels showed an inverse seasonal variation in comparison with serum 25OHD levels, with lowest median values in 
September and October. 
 
 
TABLE 2 Prevalence of vitamin D deficient and replete states by gender, season and age group a 
Severe deficiency Moderate deficiency Mild deficiency  Replete  
Men   (<12.5 nmol/l)  (12.5-25 nmol/l)  (25-50 nmol/l)  (>50 
nmo/l) 
Total (%)   2.2   13.4   41.2   43.2 
May-October 
Age group (%) 
18-34 y   0.5   10.1   33.6   55.8 
35-64 y   1.3     8.3   34.4   56.0 
65-79 y   1.4     7.0   43.3   48.3 
All ages (%)  1.1     8.7   35.4   54.8 
 
November-April 
Age group (%) 
18-34 y    2.0   18.5   47.5   32.0 
35-64 y    3.8   18.6   47.7   29.9 
65-79 y   4.2   14.8   41.6   39.4 
All ages (%)  3.3   18.1   46.8   31.8 
   Severe deficiency Moderate deficiency Mild deficiency   Replete 
Women   (<12.5 nmol/l)  (12.5-25 nmol/l)  (25-50 nmol/l)  (>50 
nmol/l) 
Total (%)   1.9   15.1   40.8   42.2 
May-October 
Age group (%) 
18-34 y   0.5     5.6   37.4   56.5 
35-64 y   1.1   10.3   41.2   47.4 
65-79 y   1.2   21.7   51.9   25.2 
All ages (%)  0.9   11.5   42.4   45.2 
 
November-April 
Age group (%) 
18-34 y   3.0   16.1   34.2   46.7 
35-64 y   3.2   16.4   41.0   39.4 
65-79 y   0.9   30.2   42.3   26.6 
All ages (%)  2.7   18.8   39.3   39.2 







Prevalence of vitamin D deficiency and seasonal variation  
We observed a high prevalence of vitamin D deficiency among German adults. Regardless of season, 
15.6% of men and 17.0% of women had severe to moderate vitamin D deficiency (o25 nmol/l). Over 
half of the population (56.8% of men and 57.8% of women) generally had serum 25OHD levels below 
50 nmol/l. Vitamin D-deficient states were most prevalent among women 65 years and older. Nearly 
75% of women in this age group had serum 25OHD levels below 50 nmol/l, even during sunnier 
months. Nevertheless, vitamin D deficiency was prevalent among younger persons. 
For example depending on seasonal changes 20.5% of men and 19.1% of women, 18 to 34-year old, 
showed severe to moderate vitamin D deficiency during sun-deprived months. To our knowledge, this 
is the first survey to examine the vitamin D status in a representative sample of the German 
noninstitutionalized adult population. As there is no consensus on an optimal vitamin D status (Lips, 
2004; Dawson- Hughes et al., 2005; Aloia et al., 2006; Bischoff-Ferrari et al., 2006) and no 
standardization of vitamin D measurement (Lips et al., 1999; Binkley et al., 2004), comparison 
between different studies and results is rather difficult. However, our data are similar to results of other 
European studies concerning the prevalence of vitamin D deficiency from various countries in Europe 
(Burnand et al., 1992; Scharla et al., 1996; Chapuy et al., 1997;Woitge et al., 1998; Lamberg- Allardt 
et al., 2001; Kudlacek et al., 2003; Ovesen et al., 2003; MacFarlane et al., 2004; Meyer et al., 2004) 
and other continents (Sherman et al., 1990; Mc Kenna, 1992; Jacques et al., 1997; Looker et al., 
2002; Rapuri et al., 2002; Hashemipour et al., 2004; Hanley and Davision, 2005), 





Figure 2 (a) The center in the box indicates the median. Boxes represent values within the twenty-fifth and seventy-fifth 
percentiles and lines represent values within the tenth and ninetieth percentiles. Serum 25OHD levels and BMI showed a 
curvilinear, U-shaped association with the lowest 25OHD levels observed in both low- and high-BMI groups (P¼0.0034). (b) The 
center in the box indicates the median. Boxes represent values within the twenty-fifth and seventy-fifth percentiles and lines 
represent values within the tenth and ninetieth percentiles. Serum 25OHD levels and BMI showed a curvilinear, U-shaped 




including countries located at low latitudes (Levis et al., 2005; Lucas et al., 2005). Moreover, studies 
considerably vary with respect to the recruitment and the age range of the included sample, and only 
few studies have been based on nationally representative samples (Chapuy et al., 1997; Finch 
et al., 1998; Looker et al., 2002; Hirani and Primatesta, 2005). The median vitamin D intake from both 
diet and supplements did not meet the recommended level of 5 mg/ day, in either men or women. 
Altogether, 80.9% of men and 88.5% of women had vitamin D intakes below the recommended level. 
In comparison with studies from northern countries concerning elderly women (Andersen et al., 2005), 
median vitamin D intakes seem to be rather small. In accordance with previous reports from a number 
of regional cross-sectional studies (Scharla et al., 1996; Woitge et al., 1998; Rapuri et al., 2002; 
Bhattoa et al., 2004), we observed considerable seasonal changes in serum 25OHD levels, with 
lowest and highest median values among participants studied in late winter (March) and summer 
(June), respectively. Serum iPTH also showed the expected inverse seasonal variation, with lowest 
median values in September and October (Woitge et al., 1998; Rapuri et al., 2002). Lack of fit between 
seasonal variation predicted from models based on the individual iPTH measurements and the 
observed variation based on median values was evident between July and September. The rise in 
median iPTH from July to August is likely to be explained by a smaller number of study participants 
(since August is the typical holiday month in Germany, the fieldwork was paused for some weeks) and 
the coincidental relatively high proportion of elderly women participating between mid July and mid 
September. This may, at least in part, also explain why the variability in serum 25OHD levels was 
observed to be larger during winter than summer. However, there are also a number of biochemical 
explanations. First, it may be that people generally have a certain degree of sunlight exposure during 
summer, partly explaining the smaller variability. Second, a larger variability in outdoor activities during 
the sun-deprived season is likely, as some participants may have traveled to sunny districts or skiing 
regions within several weeks before the survey examination. Finally, an increase in supplement use 
during winter as observed in our study population is also possible. Determinants of vitamin D status 
Given the fact that vitamin D deficiency has been implicated in many disorders, it is of high public 
health relevance to identify risk groups. We therefore examined determinants of serum 25OHD levels. 
According to our observations, Jacques et al. (1997) found an inverse relationship between serum 
25OHD levels and age among elderly women but not in men in the Framingham Heart Study.While 
there is evidence that cutaneous vitamin D biosynthesis (Holick et al., 1989) may become less efficient 
with advancing age, this would not explain the observed sex differences. Clinical as well as 
population-based studies have consistently found that obesity is associated with lower serum 25OHD 
levels (Jacques et al., 1997; Wortsman et al., 2000; Snijder et al., 2006). In contrast, there is only one 
population- based study conducted in the framework of the Health Survey for England 2000, that has 
reported a significant association between low BMI (o25 kg/m2) and vitamin D status (Hirani and 
Primatesta, 2005). In extension of these previous reports, we observed not only a high but also a low 
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TABLE 3 Independent determinants of log-serum 25OHD levels: multiple linear regression a  
Men 
Variable     B   SE  stand.B  p value 
Intercept      2.909  0.496   0.0  <0.001 
Age (per year)    -0.001  0.001  -0.026    0.333 
Body mass index (per kg/m²)    0.060  0.035   0.310    0.088 
Body mass index squared   -0.001  0.001  -0.339    0.059 
Leisure time physical activity (versus inactive) 
Moderately active (1-2 h/week)  0.058  0.041   0.037    0.154 
Active (≥ 2 h/week)    0.227   0.045   0.135  <0.001 
Season (versus autumn) 
Spring    -0.270   0.040  -0.175  <0.001 
Summer     0.234   0.049   0.124  <0.001 
Winter    -0.188   0.058  -0.081    0.001 
Time of day of blood sampling (versus morning) 
 Noon/Afternoon    0.007  0.044   0.005    0.865 
 Evening    -0.171  0.045  -0.111  <0.001 
Vitamin D intake (per µg/d) b     0.018  0.006   0.076    0.002 
Vitamin D supplement use      0.147  0.143   0.024    0.303 
Outdoor working     0.063   0.036   0.042    0.077 
Married or living with a partner   0.149   0.044   0.086   <0.001 









TABLE 4 a Prevalence (%) of chronic diseases according to quartiles of vitamin D levels a 
Men 
Quartiles     1  2  3  4 
 p value 
Hypertension    51.9  47.7  49.5  47.2 
   0.211 
 
Cardiovascular disease   11.9    9.5  10.4  10.3 
   0.517 
 
Insulin treated diabetes mellitus     3.0    0.3    0.8    0.4 
 <0.001 
 
Non-insulin treated diabetes mellitus      4.0    2.7    5.4    2.6 




Quartiles      1  2  3  4 
 p value 
Hypertension    50.1  48.1  40.9  30.1 
 <0.001 
 
Cardiovascular disease   16.7  13.1    9.4    5.6 
 <0.001 
 
Insulin treated diabetes mellitus    2.3    0.1    1.5    0.8 
   0.123 
 
Non-insulin treated diabetes mellitus      6.5    6.5    4.4    1.5 
 <0.001 
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TABLE 4 b Relationship between serum 25OHD levels and chronic diseases (Odds Ratio and 95% Confidence Intervals) a 
 
Men 
       Odds Ratio   p value 
Hypertension      0.97 (0.94-0.99)  0.036 
 
Cardiovascular disease     0.95 (0.90-1.01)  0.080 
 
Insulin treated diabetes mellitus    0.67 (0.53-0.86)  0.001 
  




       Odds Ratio   p value 
Hypertension      0.96 (0.93-0.99)  0.030 
 
Cardiovascular disease     0.94 (0.89-0.99)  0.040 
 
Insulin treated diabetes mellitus    0.89 (0.76-1.06)  0.205 
 
Non-insulin treated diabetes mellitus   0.91 (0.83-1.00)  0.051 
a From separate logistic models including serum 25OHD levels (per 10 nmol/l) as continuous variable, adjusted for age, season and time of 





BMI to be associated with low serum 25OHD levels. A recent study suggests that decreased 
bioavailability due to its deposition in body fat is responsible for low serum 25OHD levels in obese 
subjects (Wortsman et al., 2000). It is also possible that obese as well as very lean persons may be 
less exposed to sunlight as they are less often outdoor or wear more covering clothing. Residual 
confounding of sunlight exposure is possible, since we had to rely on proxy variables to control for UV 
exposure. As underweight persons may be prone to vitamin D deficiency due to inadequate food 
consumption, we examined the association between serum 25OHD levels and the ratio of EI to REE 
(EI/REE) (Wortsman et al., 2000) as measure of adequate food consumption. It is 
often observed that EI/REE correlates strongly with BMI (Mensink et al., 2001). Low-energy reporting 
as determined by a low ratio of EI/REE is positively associated with BMI. In the regression model we 
included this ratio to analyze the impact of low-energy reporters. Since the influence was not relevant 
and EI/REE showed collinearity with BMI, it was not included in the presented models. 
We did not observe a significant relationship between vitamin D supplement use and serum 25OHD 
levels in either gender. Andersen et al. (2005) reported that vitamin D supplement use was a 
significant determinant of serum 25 OHD levels in postmenopausal women living in northern 
Europe. Our study is a representative of nationwide survey including adults from 18 to 79 years of age. 
In this group, the observed proportion of vitamin D supplement users was very small compared to 
postmenopausal women in the previous study. We can, however, not exclude misclassification due to 
imprecise questions concerning vitamin D supplement use. Persons who are married or live with a 
partner are known to be generally healthier than singles (Joutsenniemi et al., 2006) and more active in 
their leisure time (Pettee et al., 2006). We therefore hypothesized that these groups may spend more 
time outdoors and have a more balanced diet than singles. While the observed significant and 
independent positive association between vitamin D status and living in a partnership does not prove 
any of the particular mechanisms, it is likely to serve as a proxy for differences in health-related 
behavior that was not captured by the constructs of ‘physical activity’ or ‘vitamin D intake’. To exclude 
possible effects of diurnal variation of serum 25OHD levels, we included time of day of blood sampling 
in our analyses. In men, but not in women, we found a significant relationship with serum 25OHD 
levels, increasing from morning to noon/afternoon and strongly declining until evening. The sex 
difference disappeared when we confined the analyses to younger women up to the age of 50 years, 
which may indicate an interrelationship with sex hormone metabolism. To our knowledge, this is the 
first observation of diurnal variation in serum 25-OHD. Diurnal rhythm of 1,25-dihydroxyvitamin D and 
other markers of bone mineral metabolism was shown previously (Greenspan et al., 1997; Rejnmark 
et al., 2002). Multiple regression models explained only a small fraction of the variance in vitamin D 
status. It is likely that this is largely attributable to difficulties in the estimation of sunlight exposure, as 
we had no information on time spent outdoors, traveling to sunny regions, clothing habits, use of 
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sunscreen or grade of skin pigmentation. We could also not consider genetic factors such as vitamin D 
receptor gene polymorphism (Zajickova et al., 2006). 
 
Role of diseases 
Due to the increasing number of studies implicating vitamin D deficiency in the pathogenesis of 
various chronic disorders, we also examined the cross-sectional relationship between serum 25OHD 
levels and chronic conditions. There is strong evidence for a role of hypovitaminosis D in type 1 
diabetes mellitus. Hyppönen et al. (2001) found that children, studied at 1 year of age, who took a 
recommended dose of vitamin D during infancy, were only one-fifth likely to develop type 1 diabetes 
mellitus compared to those who received less than the recommended amount. We were not able to 
precisely distinguish between type 1 and type 2 diabetes mellitus. Based on medical history regarding 
the first onset of disease and insulin treatment, the vast majority of our diabetics can be assumed to 
have had type 2 diabetes mellitus. An association of vitamin D with type 2 diabetes is more 
controversial, and may be more pronounced in insulintreated type 2 diabetics (Scragg et al., 2004; 
Suzuki et al., 2006). This may explain why we observed a stronger association with insulin-treated 
than noninsulin-treated diabetes, at least among men. There is potential for misclassification bias due 
to undiagnosed diabetes, which would have weakened the association between serum 25OHD and 
noninsulin-treated diabetes mellitus. It is well possible that the observed sex differences result from a 
small number of insulin-treated diabetics as well as a higher proportion of undiagnosed disease 
among men than women (Scheidt-Nave et al., 1990; Rathmann et al., 2003). Recent reviews suggest 
that suboptimal vitamin D status may also play a role in the development of other chronic diseases 
including hypertension and cardiovascular diseases (Zittermann, 2003; Holick, 2004a, b). In adjusted 
models, hypertension was related to 25OHD in both sexes, whereas a significant association with 
cardiovascular disease was also restricted to women. At any rate, our study is cross sectional with the 
consequence that causality cannot be inferred. Only longitudinal studies are capable to identify 
disorders due to long-standing vitamin D deficiency. 
 
Study limitations 
Based on blood specimens and highly standardized interview methods including assessment of diet 
and supplement use, the German National Health Interview and Examination Survey provided a 
unique source of data to assess vitamin D status at the population level. Results were weighted with a 
factor adjusting for deviations in demographic characteristics between the study populations and 
official population statistics at the time of the survey. Therefore, the reported results can be extended 
to the noninstitutionalized adult population residing in Germany in 1998. Our study also has several 
major limitations. Mainly, a detailed history of sunlight exposure was not assessed at the time of the 
survey. Synthesis of vitamin D in the skin under UV exposure essentially contributes to maintain 
vitamin D supplies, and an effect of ultraviolet radiation on serum 25OHD concentrations can be 
expected within 4–8 weeks of exposure (Chel et al., 1998; Lucas et al., 2005). In the present 
study, season, outdoor working as well as leisure-time physical activity served as proxy measures of 
this effect. We can therefore not exclude misclassification with possible bias of effect estimates in the 
regression model. A further limitation may be the possible measurement errors in the dietary 
assessment. While it has been shown previously that dietary vitamin D in general only contributes in a 
small part to vitamin D status in comparison with UV radiation, the influence may increase in winter 
(Ovesen et al., 2003). Our survey explicitly excluded persons who were not fluently speaking German. 
Thus, persons with a migrant background, who are known to be at particularly high risk of vitamin D 
deficiency (Meyer et al., 2004), are underrepresented. The presence or absence of chronic disease 
was based on self-report (ever diagnosed by a physician), except for hypertension. Information on 
morbidity was obtained from various sources, including self-administered questionnaires prompting 
study participants with a list of conditions as well as detailed computer-assisted health interviews 
regarding a lifetime diagnosis by a physician, year of first onset, presence of the condition within the 
past 12 months or 4 weeks and current medication use. Using this information, a selfreported 
diagnosis of diabetes mellitus and several cardiovascular conditions have previously been found 
highly reliable and reasonably valid in German national health surveys (Bormann et al., 1990; Thefeld, 
1999). Nevertheless, misclassification bias remains an issue, as persons who are yet undiagnosed as 
well as those who may have not participated due to advanced illness or hospitalization will be missed 
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Our results demonstrate that moderate and mild vitamin D deficiency affects a large proportion of the 
adult population in Germany, and is already prevalent in younger age groups. Specific risk groups 
include women 65 years of age and older, obese as well as very lean persons. Together with the 
observed demographic shift toward an elderly population in Germany, this is a serious public health 
problem. Attention should be paid to optimizing vitamin D status, in both young and elderly persons. 
Regular outdoor activities (while paying attention to the risk of skin cancer due to unprotected or 
prolonged sun exposure) should be considered as well as optimizing vitamin D intake, in particular 
during winter. To clarify in how far our observations have implications on health and health care 
responsibilities, in particular preventive actions, prospective observational and interventional studies 
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